Fig. 2.
Fig. 2. The release of PMNBrdU into the circulation after IV IL-8 (2.5 μg/kg) (n = 4) or saline (n = 4). BrdU was infused 24 hours before the IL-8 was administered. At time 0, the percentage of PMNBrdU in the circulation was less than 2% (A). IL-8 induced a rapid increase in the percentage of PMNBrdU in the circulation, which remained higher than the controls for 90 minutes (*P < .05 v control). (B) Shows the absolute number of PMNBrdU in the circulation. After IV IL-8, the number of circulating PMNBrdU increased and peaked at 60 minutes, then gradually declined to baseline levels at 180 minutes. The control group showed no change in either the percentage or the number of PMNBrdU during the 180-minute study period. Values are mean ± SEM.

The release of PMNBrdU into the circulation after IV IL-8 (2.5 μg/kg) (n = 4) or saline (n = 4). BrdU was infused 24 hours before the IL-8 was administered. At time 0, the percentage of PMNBrdU in the circulation was less than 2% (A). IL-8 induced a rapid increase in the percentage of PMNBrdU in the circulation, which remained higher than the controls for 90 minutes (*P < .05 v control). (B) Shows the absolute number of PMNBrdU in the circulation. After IV IL-8, the number of circulating PMNBrdU increased and peaked at 60 minutes, then gradually declined to baseline levels at 180 minutes. The control group showed no change in either the percentage or the number of PMNBrdU during the 180-minute study period. Values are mean ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal